Insulet (NASDAQ:PODD) vs. United Health Products (OTCMKTS:UEEC) Financial Analysis

Insulet (NASDAQ:PODD) and United Health Products (OTCMKTS:UEEC) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, risk and earnings.

Insider & Institutional Ownership

0.1% of United Health Products shares are owned by institutional investors. 0.4% of Insulet shares are owned by company insiders. Comparatively, 1.5% of United Health Products shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Risk & Volatility

Insulet has a beta of 1.42, indicating that its share price is 42% more volatile than the S&P 500. Comparatively, United Health Products has a beta of -0.89, indicating that its share price is 189% less volatile than the S&P 500.

Profitability

This table compares Insulet and United Health Products’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Insulet	9.12%	24.90%	10.73%
United Health Products	N/A	N/A	-2,141.74%

Valuation and Earnings

This table compares Insulet and United Health Products”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Insulet	$2.71 billion	6.31	$247.10 million	$3.50	69.40
United Health Products	N/A	N/A	-$2.00 million	($0.02)	-3.00

Insulet has higher revenue and earnings than United Health Products. United Health Products is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Insulet and United Health Products, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Insulet	1	3	20	0	2.79
United Health Products	0	0	0	0	0.00

Insulet presently has a consensus target price of $354.57, indicating a potential upside of 45.98%. Given Insulet’s stronger consensus rating and higher possible upside, research analysts plainly believe Insulet is more favorable than United Health Products.

Summary

Insulet beats United Health Products on 11 of the 13 factors compared between the two stocks.

About Insulet

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

About United Health Products

United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey.